Indian vaccine maker looks to raise $1B for COVID-19 shot manufacturing, trial efforts: report

The Serum Institute of India (SII) is pursuing $1 billion in fundraising by September to support development of five COVID-19 vaccine candidates, including frontrunners from AstraZeneca and Novavax, the Economic Times of India reported.